|
1
|
Balamuth NJ and Womer RB: Ewing's sarcoma.
Lancet Oncol. 11:184–192. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Sand LG, Szuhai K and Hogendoorn PC:
Sequencing overview of ewing sarcoma: A journey across genomic,
epigenomic and transcriptomic landscapes. Int J Mol Sci.
16:16176–16215. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kovar H, Alonso J, Aman P, Aryee DN, Ban
J, Burchill SA, Burdach S, De Alava E, Delattre O, Dirksen U, et
al: The first European interdisciplinary ewing sarcoma research
summit. Front Oncol. 2:542012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Paulussen M, Ahrens S, Burdach S, Craft A,
Dockhorn-Dworniczak B, Dunst J, Fröhlich B, Winkelmann W, Zoubek A
and Jürgens H: Primary metastatic (stage IV) Ewing tumor: Survival
analysis of 171 patients from the EICESS studies. European
intergroup cooperative ewing sarcoma studies. Ann Oncol. 9:275–281.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Postel-Vinay S, Veron AS, Tirode F,
Pierron G, Reynaud S, Kovar H, Oberlin O, Lapouble E, Ballet S,
Lucchesi C, et al: Common variants near TARDBP and EGR2 are
associated with susceptibility to Ewing sarcoma. Nat Genet.
44:323–327. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Delattre O, Zucman J, Plougastel B,
Desmaze C, Melot T, Peter M, Kovar H, Joubert I, de Jong P, Rouleau
G, et al: Gene fusion with an ETS DNA-binding domain caused by
chromosome translocation in human tumours. Nature. 359:162–165.
1992. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Delattre O, Zucman J, Melot T, Garau XS,
Zucker JM, Lenoir GM, Ambros PF, Sheer D, Turc-Carel C, Triche TJ,
et al: The Ewing family of tumors-a subgroup of small-round-cell
tumors defined by specific chimeric transcripts. N Engl J Med.
331:294–299. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Sorensen PH, Lessnick SL, Lopez-Terrada D,
Liu XF, Triche TJ and Denny CT: A second Ewing's sarcoma
translocation, t(21;22), fuses the EWS gene to another ETS-family
transcription factor, ERG. Nat Genet. 6:146–151. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Potratz J, Dirksen U, Jurgens H and Craft
A: Ewing sarcoma: Clinical state-of-the-art. Pediatr Hematol Oncol.
29:1–11. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Jeon IS, Davis JN, Braun BS, Sublett JE,
Roussel MF, Denny CT and Shapiro DN: A variant Ewing's sarcoma
translocation (7;22) fuses the EWS gene to the ETS gene ETV1.
Oncogene. 10:1229–1234. 1995.PubMed/NCBI
|
|
11
|
Kaneko Y, Yoshida K, Handa M, Toyoda Y,
Nishihira H, Tanaka Y, Sasaki Y, Ishida S, Higashino F and Fujinaga
K: Fusion of an ETS-family gene, EIAF, to EWS by t(17;22)(q12;q12)
chromosome translocation in an undifferentiated sarcoma of infancy.
Genes Chromosomes Cancer. 15:115–121. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Peter M, Couturier J, Pacquement H, Michon
J, Thomas G, Magdelenat H and Delattre O: A new member of the ETS
family fused to EWS in Ewing tumors. Oncogene. 14:1159–1164. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Folpe AL, Hill CE, Parham DM, O'Shea PA
and Weiss SW: Immunohistochemical detection of FLI-1 protein
expression: A study of 132 round cell tumors with emphasis on
CD99-positive mimics of Ewing's sarcoma/primitive neuroectodermal
tumor. Am J Surg Pathol. 24:1657–1662. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Rossi S, Orvieto E, Furlanetto A, Laurino
L, Ninfo V and Dei Tos AP: Utility of the immunohistochemical
detection of FLI-1 expression in round cell and vascular neoplasm
using a monoclonal antibody. Mod Pathol. 17:547–552. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lin O, Filippa DA and Teruya-Feldstein J:
Immunohistochemical evaluation of FLI-1 in acute lymphoblastic
lymphoma (ALL): A potential diagnostic pitfall. Appl
Immunohistochem Mol Morphol. 17:409–412. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Savola S, Klami A, Myllykangas S, Manara
C, Scotlandi K, Picci P, Knuutila S and Vakkila J: High expression
of complement component 5 (C5) at tumor site associates with
superior survival in Ewing's sarcoma family of tumour patients.
ISRN Oncol. 2011:1687122011.PubMed/NCBI
|
|
17
|
Leek JT, Johnson WE, Parker HS, Jaffe AE
and Storey JD: The sva package for removing batch effects and other
unwanted variation in high-throughput experiments. Bioinformatics.
28:882–883. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Diboun I, Wernisch L, Orengo CA and
Koltzenburg M: Microarray analysis after RNA amplification can
detect pronounced differences in gene expression using limma. BMC
Genomics. 7:2522006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Huang da W, Sherman BT and Lempicki RA:
Systematic and integrative analysis of large gene lists using DAVID
bioinformatics resources. Nat Protoc. 4:44–57. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Merico D, Isserlin R, Stueker O, Emili A
and Bader GD: Enrichment map: A network-based method for gene-set
enrichment visualization and interpretation. PLoS One.
5:e139842010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kohl M, Wiese S and Warscheid B:
Cytoscape: Software for visualization and analysis of biological
networks. Methods Mol Biol. 696:291–303. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Cowley MJ, Pinese M, Kassahn KS, Waddell
N, Pearson JV, Grimmond SM, Biankin AV, Hautaniemi S and Wu J: PINA
v2.0: Mining interactome modules. Nucleic Acids Res. 40(Database
Issue): D862–D865. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Menche J, Sharma A, Kitsak M, Ghiassian
SD, Vidal M, Loscalzo J and Barabási AL: Disease networks.
Uncovering disease-disease relationships through the incomplete
interactome. Science. 347:12576012015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Xie C, Mao X, Huang J, Ding Y, Wu J, Dong
S, Kong L, Gao G, Li CY and Wei L: KOBAS 2.0: A web server for
annotation and identification of enriched pathways and diseases.
Nucleic Acids Res. 39:W316–W322. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hamanoue S and Makimoto A: Ewing sarcoma.
Gan To Kagaku Ryoho. 34:175–180. 2007.(In Japanese). PubMed/NCBI
|
|
27
|
Ray-Coquard I and Le Cesne A: A role for
maintenance therapy in managing sarcoma. Cancer Treat Rev.
38:368–378. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Fearon KC, Glass DJ and Guttridge DC:
Cancer cachexia: Mediators, signaling, and metabolic pathways. Cell
Metab. 16:153–166. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Waning DL, Mohammad KS, Reiken S, Xie W,
Andersson DC, John S, Chiechi A, Wright LE, Umanskaya A, Niewolna
M, et al: Excess TGF-β mediates muscle weakness associated with
bone metastases in mice. Nat Med. 21:1262–1271. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
He Y, Yan D, Zheng D, Hu Z, Li H and Li J:
Cell division cycle 6 promotes mitotic slippage and contributes to
drug resistance in paclitaxel-treated cancer cells. PLoS One.
11:e01626332016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Yan B, Ouyang R, Huang C, Liu F, Neill D,
Li C and Dewhirst M: Heat induces gene amplification in cancer
cells. Biochem Biophys Res Commun. 427:473–477. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Rui L: Energy metabolism in the liver.
Compr Physiol. 4:177–197. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ma R, Zhang W, Tang K, Zhang H, Zhang Y,
Li D, Li Y, Xu P, Luo S, Cai W, et al: Switch of glycolysis to
gluconeogenesis by dexamethasone for treatment of hepatocarcinoma.
Nat Commun. 4:25082013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Khan MW and Chakrabarti P: Gluconeogenesis
combats cancer: Opening new doors in cancer biology. Cell Death
Dis. 6:e18722015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Xu X, Chen D, Ye B, Zhong F and Chen G:
Curcumin induces the apoptosis of non-small cell lung cancer cells
through a calcium signaling pathway. Int J Mol Med. 35:1610–1616.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Ventura S, Aryee DN, Felicetti F, De Feo
A, Mancarella C, Manara MC, Picci P, Colombo MP, Kovar H, Carè A
and Scotlandi K: CD99 regulates neural differentiation of Ewing
sarcoma cells through miR-34a-Notch-mediated control of NF-kB
signaling. Oncogene. 35:3944–3954. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Tetsu O and McCormick F: Beta-catenin
regulates expression of cyclin D1 in colon carcinoma cells. Nature.
398:422–426. 1999. View
Article : Google Scholar : PubMed/NCBI
|
|
38
|
Li H, Liu L, David ML, Whitehead CM, Chen
M, Fetter JR, Sperl GJ, Pamukcu R and Thompson WJ: Pro-apoptotic
actions of exisulind and CP461 in SW480 colon tumor cells involve
beta-catenin and cyclin D1 down-regulation. Biochem Pharmacol.
64:1325–1336. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Ren Y, Zheng J, Yao X, Weng G and Wu L:
Essential role of the cGMP/PKG signaling pathway in regulating the
proliferation and survival of human renal carcinoma cells. Int J
Mol Med. 34:1430–1438. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Lv Y, Fang M, Zheng J, Yang B, Li H,
Xiuzigao Z, Song W, Chen Y and Cao W: Low-intensity ultrasound
combined with 5-aminolevulinic acid administration in the treatment
of human tongue squamous carcinoma. Cell Physiol Biochem.
30:321–333. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Seo SR and Seo JT: Calcium overload is
essential for the acceleration of staurosporine-induced cell death
following neuronal differentiation in PC12 cells. Exp Mol Med.
41:269–276. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Ma TS: Sarcoplasmic reticulum calcium
ATPase overexpression induces cellular calcium overload and cell
death. Ann N Y Acad Sci. 853:325–328. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Narendra D, Kane LA, Hauser DN, Fearnley
IM and Youle RJ: p62/SQSTM1 is required for Parkin-induced
mitochondrial clustering but not mitophagy; VDAC1 is dispensable
for both. Autophagy. 6:1090–1106. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Shamir R, Klein C, Amar D, Vollstedt EJ,
Bonin M, Usenovic M, Wong YC, Maver A, Poths S, Safer H, et al:
Analysis of blood-based gene expression in idiopathic Parkinson
disease. Neurology. 89:1676–1683. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Bajaj A, Driver JA and Schernhammer ES:
Parkinson's disease and cancer risk: A systematic review and
meta-analysis. Cancer Causes Control. 21:697–707. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Diaz-Moralli S, Tarrado-Castellarnau M,
Miranda A and Cascante M: Targeting cell cycle regulation in cancer
therapy. Pharmacol Ther. 138:255–271. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Ding Y, Hubert CG, Herman J, Corrin P,
Toledo CM, Skutt-Kakaria K, Vazquez J, Basom R, Zhang B, Risler JK,
et al: Cancer-Specific requirement for BUB1B/BUBR1 in human brain
tumor isolates and genetically transformed cells. Cancer Discov.
3:198–211. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Fu X, Chen G, Cai ZD, Wang C, Liu ZZ, Lin
ZY, Wu YD, Liang YX, Han ZD, Liu JC and Zhong WD: Overexpression of
BUB1B contributes to progression of prostate cancer and predicts
poor outcome in patients with prostate cancer. Onco Targets Ther.
9:2211–2220. 2016.PubMed/NCBI
|
|
49
|
Zhao WM and Fang G: MgcRacGAP controls the
assembly of the contractile ring and the initiation of cytokinesis.
Proc Natl Acad Sci USA. 102:13158–13163. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Kitamura T, Kawashima T, Minoshima Y,
Tonozuka Y, Hirose K and Nosaka T: Role of MgcRacGAP/Cyk4 as a
regulator of the small GTPase Rho family in cytokinesis and cell
differentiation. Cell Struct Funct. 26:645–651. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Imaoka H, Toiyama Y, Saigusa S, Kawamura
M, Kawamoto A, Okugawa Y, Hiro J, Tanaka K, Inoue Y, Mohri Y and
Kusunoki M: RacGAP1 expression, increasing tumor malignant
potential, as a predictive biomarker for lymph node metastasis and
poor prognosis in colorectal cancer. Carcinogenesis. 36:346–354.
2015. View Article : Google Scholar : PubMed/NCBI
|
